- Intellectual Property
- International Patent
- Life Sciences
- Technology Transfer & Licensing
- Patent Procurement
|Contact Info||Telephone: 617.348.1871|
Internet: Each Attorney's Internet Address takes the following form: first initial, last name @mintz.com (e.g., email@example.com)
|University ||University of Texas, B.A.; University of Texas Southwestern Medical Center, Ph.D., Molecular Biology|
|Law School||Suffolk University, J.D., With Distinction|
|Admitted||2011, Massachusetts; U.S. Patent & Trademark Office|
Dan's practice involves domestic and foreign patent prosecution primarily in the area of biotechnology, including the fields of cellular and molecular biology, oncology, immunology, microbiology, genetic engineering, biochemistry, pharmaceuticals, stem cells, RNAi, medical devices, and probiotics, among others.
Dan is experienced in drafting patent validity and infringement opinions, freedom-to-operate opinions, and due diligence evaluations of patent portfolios. He has worked with a broad range of clients, from small biotech start-ups to universities and established pharmaceutical companies. Dan has also authored and presented scientific publications in the fields of immunology, microbiology, parasitology, and ophthalmology.
Dan was a Technology Specialist then an Associate with Mintz Levin for several years before practicing as an Associate with another international law firm. Dan rejoined Mintz Levin in 2014.
Dan's doctoral dissertation focused on characterizing the pathogenic cascade of Acanthamoeba keratitis, a sight-threatening infection of the ocular surface. He was also the recipient of a doctoral training fellowship awarded by UT Southwestern and a grant-in-aid of research from the National Academy of Sciences, awarded by Sigma Xi, the Scientific Research Society.
Recognitions & Awards
• Best Legal Brief in the First Year Legal Practice Skills Program, Suffolk University
Professional & Community Involvement
• Member, Boston Bar Association
• Member, Boston Patent Law Association
• Member, Sigma Xi, the Scientific Research Society
• Co-author, Supreme Court Invalidates Biotech Method Patent in Mayo v. Prometheus, Intellectual Property Alert (03.26.2012)
• Co-author, Do You Qualify for the "Micro Entity" Discount?, Intellectual Property Alert (11.03.2011)
Documents by this lawyer on Martindale.com
U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
Daniel W. Clarke,Peter F. Corless,Christopher R. Cowles,Ralph A. Loren, March 11, 2014
On March 4, 2014, the United States Patent and Trademark Office (USPTO) issued a highly anticipated Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena & Natural Products (“Guidance”). The Guidance is promulgated for...
|Profile Visibility |
|#1,342 in weekly profile views out of 20,115 lawyers in Boston, Massachusetts|
|#116,095 in weekly profile views out of 1,673,393 total lawyers Overall|